CDC, rabies, pox, viruses, antidepressants, meth: Morning Rounds
Healthcare has once again reclaimed the top spot on Americans’ list of domestic worries, according to a recent Gallup poll. Staying informed on the latest news and developments in the healthcare industry can help combat this concern. To get your daily dose of health and medicine news, sign up for STAT’s free newsletter Morning Rounds.
In recent news, the CDC has announced a temporary pause in diagnostic testing for rabies and pox viruses. This decision has raised concerns about the agency’s capacity to address health threats, especially in the absence of a director and amid staff dissatisfaction with the Trump administration. Former CDC chief medical officer Deb Houry has highlighted the impact of losing scientific expertise on public safety.
FDA Commissioner Marty Makary recently marked the anniversary of his tenure with a speech to agency staff. However, ongoing workplace turbulence at the FDA has raised questions about the agency’s stability following significant layoffs during the previous administration. Makary’s speech left out crucial topics, indicating potential challenges ahead.
Medical misinformation is increasingly hindering doctors’ ability to care for patients, with more than half of physicians reporting its negative impact. As access to medical professionals decreases nationwide, patients are turning to the internet for health information, leading to potentially harmful consequences. Physician Ilana Yurkiewicz emphasizes the importance of debunking false claims and communicating effectively with patients.
A recent study tested radiologists’ ability to differentiate between real and AI-generated X-rays, with results showing a 75% accuracy rate. This highlights the potential challenges of detecting deepfake images in medical diagnostics. The study’s findings underscore the importance of noise and consistency within images for accurate interpretation.
In the realm of addiction treatment, a recent study published in JAMA Psychiatry explored the use of the antidepressant mirtazapine for methamphetamine use disorder. Participants who received mirtazapine showed a significant reduction in methamphetamine use compared to those who received a placebo. While the findings are promising, adverse reactions such as drowsiness and weight gain were reported among some participants.
As the healthcare landscape continues to evolve, it is crucial to stay informed on the latest developments and research in the field. By prioritizing prevention and effective communication with patients, healthcare professionals can navigate the challenges posed by medical misinformation and limited access to care. Stay updated on healthcare news and trends to ensure optimal health outcomes for all.
